Page last updated: 2024-08-22

angiotensin ii and Electron Transport Chain Deficiencies, Mitochondrial

angiotensin ii has been researched along with Electron Transport Chain Deficiencies, Mitochondrial in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, Y; Gao, P; Li, L; Li, Y; Lin, S; Liu, D; Lu, Z; Wang, B; Wei, X; Xiong, S; Zhang, H; Zhao, Z; Zhu, Z1
Heron, RJ1
Bian, Z; Chen, X; Gu, C; Li, S; Lu, Y; Wu, H; Xu, J; Yang, D1
Baumann, M; Eriksson, O; Finckenberg, P; Haasio, K; Kytö, V; Lalowski, MM; Levijoki, J; Luft, FC; Merasto, S; Mervaala, E; Muller, DN; Oresic, M1
de Cavanagh, EM; Ferder, L; Ferder, M; Inserra, F1
Dikalov, SI; Doughan, AK; Harrison, DG1

Reviews

1 review(s) available for angiotensin ii and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
From mitochondria to disease: role of the renin-angiotensin system.
    American journal of nephrology, 2007, Volume: 27, Issue:6

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus; Humans; Hypertension; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System

2007

Other Studies

5 other study(ies) available for angiotensin ii and Electron Transport Chain Deficiencies, Mitochondrial

ArticleYear
Activation of Transient Receptor Potential Melastatin Subtype 8 Attenuates Cold-Induced Hypertension Through Ameliorating Vascular Mitochondrial Dysfunction.
    Journal of the American Heart Association, 2017, Aug-02, Volume: 6, Issue:8

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Calcium; Cell Respiration; Cells, Cultured; Cold Temperature; Dietary Supplements; Homeostasis; Hypertension; Male; Menthol; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Muscle; Mitochondrial Diseases; Muscle, Smooth, Vascular; Reactive Oxygen Species; rho-Associated Kinases; TRPM Cation Channels; Vasoconstriction

2017
Response to "The unknown: respiratory effects of cleaning up an oil spill".
    The Lancet. Respiratory medicine, 2013, Volume: 1, Issue:5

    Topics: Angiotensin II; Animals; Endothelial Cells; Mitochondrial Diseases; Oxidative Stress; Vascular Diseases; Vasoconstrictor Agents

2013
Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells.
    International journal of molecular medicine, 2015, Volume: 36, Issue:5

    Topics: Adenosine Triphosphate; Angiotensin II; Animals; Antioxidants; Cells, Cultured; DNA, Mitochondrial; Male; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NADPH Oxidases; Oxidation-Reduction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Signal Transduction; Transcription Factors; Triterpenes

2015
Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy.
    Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:1

    Topics: Angiotensin II; Angiotensinogen; Animals; Apoptosis; Autophagy; Blood Pressure; Body Temperature; Caloric Restriction; Cardiomegaly; Endoplasmic Reticulum Stress; Energy Metabolism; Heart Rate; Humans; Mitochondria; Mitochondrial Diseases; Myocytes, Cardiac; Oxidative Stress; Proteome; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Renin; Survival Rate; Vasoconstrictor Agents

2012
Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction.
    Circulation research, 2008, Feb-29, Volume: 102, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Cattle; Cell Respiration; Cells, Cultured; Endothelial Cells; Glutathione; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; Nitric Oxide; Oxidative Stress; Superoxides; Vascular Diseases; Vasoconstrictor Agents

2008